At MedEngine, we are a team of over 40 pharmaceutical professionals based in Helsinki, Copenhagen, and Stockholm. We are actively engaged in a variety of market access and Nordic real-world data projects, with a specialization in rare disease access.
Our work leverages Nordic data to develop innovative payer solutions. Additionally, this data has versatile applications, including real-world evidence (RWE) studies, post-authorization safety studies (PASS), machine learning-based algorithm development, and the development of virtual control arms for clinical trials.
We are also well-equipped to design and execute data-driven activities, ranging from Market Access landscape analysis to digital stakeholder engagement. We work with Nordic, European, and global teams of our pharmaceutical customers.